Sectoral Asset Management Inc Collegium Pharmaceutical, Inc Transaction History

Sectoral Asset Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$15.78 - $20.82 $10.3 Million - $13.6 Million	-654,521 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $3.25 Million - $4.94 Million	210,000 Added 47.24%	654,521 $11.5 Million
Q1 2020 May 13, 2020	SELL	$13.89 - $25.45 $4.35 Million - $7.97 Million	-313,326 Reduced 41.34%	444,521 $7.26 Million
Q4 2019 Feb 12, 2020	SELL	$10.7 - $22.24 $1.58 Million - $3.28 Million	-147,400 Reduced 16.28%	757,847 $15.6 Million
Q3 2019 Nov 14, 2019	SELL	$10.16 - $13.28 $2.74 Million - $3.58 Million	-269,600 Reduced 22.95%	905,247 $10.4 Million
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $2.55 Million - $3.99 Million	240,513 Added 25.74%	1,174,847 $15.4 Million
Q1 2019 May 14, 2019	SELL	$13.58 - $18.72 $3.02 Million - $4.17 Million	-222,600 Reduced 19.24%	934,334 $14.1 Million
Q4 2018 Feb 12, 2019	SELL	$14.78 - $19.68 $12.3 Million - $16.4 Million	-832,521 Reduced 41.85%	1,156,934 $19.9 Million
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $12.4 Million - $21.3 Million	876,322 Added 78.73%	1,989,455 $29.3 Million
Q2 2018 Aug 13, 2018	SELL	$21.79 - $28.29 $2.69 Million - $3.49 Million	-123,401 Reduced 9.98%	1,113,133 $26.5 Million
Q1 2018 May 15, 2018	SELL	$18.15 - $29.21 $3.45 Million - $5.56 Million	-190,328 Reduced 13.34%	1,236,534 $31.6 Million
Q4 2017 Feb 13, 2018	SELL	$9.3 - $19.14 $3 Million - $6.17 Million	-322,595 Reduced 18.44%	1,426,862 $26.3 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $16 Million - $20.9 Million	1,749,457	1,749,457 $18.4 Million

255

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $978M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.